Stock listing
A2GS5D Stock Price, News, Filings & Events — Dermapharm Holding Se
Selected listing: A2GS5D · LS · EUR · DE
This page tracks Dermapharm Holding Se's A2GS5D:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2GS5D:LS. A2GS5D:LS is the stock-level entry point for investors researching Dermapharm Holding Se, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2GS5D:LS
- Asset type
- Stock
- Market cap
- $2.31B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Dermapharm Holding Se A2GS5D:LS stock context
This page tracks Dermapharm Holding Se's A2GS5D:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2GS5D:LS. A2GS5D:LS is the stock-level entry point for investors researching Dermapharm Holding Se, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Dermapharm Holding Se
Dermapharm Holding SE performs in line with projections in Q1 2026 and confirms guidance
May 13, 2026
Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin
March 31, 2026
Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
March 26, 2026
Dermapharm Holding SE resolves public share buyback offer for up to 4,300,000 shares
March 10, 2026
Dermapharm Holding SE records decline in consolidated revenue, adjusted consolidated EBITDA improves
March 10, 2026
Dermapharm Holding Se earnings calls
Research Dermapharm Holding Se
Dermapharm Holding Se investor report
Review AI stock analysis and investor report context for A2GS5D:LS.
Dermapharm Holding Se company profile
View the public company page for Dermapharm Holding Se on 6ix.
Dermapharm Holding Se news
Read company news and market updates connected to Dermapharm Holding Se.
Dermapharm Holding Se investor events
Find investor webinars, events, and replay context for Dermapharm Holding Se.
Alternate listings
DMP:XETR
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:TRADEGATE
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:GETTEX
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:SWB
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
A2GS5D:LSX
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
0A5J:LSIN
GB · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMPHF:OTC
US · USD
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:FWB
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:HAN
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:BX
CH · CHF
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:DUS
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.
DMP:HAM
DE · EUR
Alternate listing for Dermapharm Holding Se; the primary context on this page is A2GS5D:LS.